Form 4: Altimmune CFO Gregory L. Weaver Acquires 10,000 Shares of Common Stock

Altimmune's Chief Financial Officer, Gregory L. Weaver, recently purchased 10,000 shares of the company's common stock at an average price of $5.1996 per share.

Summary

• On March 13, 2025, Gregory L. Weaver, the Chief Financial Officer of Altimmune, Inc., acquired 10,000 shares of Altimmune's common stock.
• The purchase was made at a weighted average price of $5.1996 per share.
• The shares were bought in multiple transactions with prices ranging from $5.1950 to $5.1997, inclusive.
• Following the transaction, Mr. Weaver directly owns 10,000 shares of Altimmune's common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's purchase suggests confidence, but it's a relatively small transaction and doesn't provide definitive insight into the company's overall health.

Positives

• The CFO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often viewed as a positive sign, suggesting that a company insider believes the company's stock is undervalued or that the company's prospects are strong. However, it's just one data point and should be considered alongside other factors when evaluating a company.

Stakeholder Impact

• Shareholders may view the CFO's purchase as a positive signal.

Key Dates